Evidence map›Paper›PMID 36506463›Full record

ArticleFrontiers in aging2022

Corrigendum: The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside.

María B Birkisdóttir, Ivar van Galen, Renata M C Brandt, Sander Barnhoorn, Nicole van Vliet, Claire van Dijk, Bhawani Nagarajah, Sandra Imholz, Conny T van Oostrom, Erwin Reiling and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in aging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

María B BirkisdóttirPrincess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Ivar van GalenPrincess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Renata M C BrandtDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.
Sander BarnhoornDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.
Nicole van VlietDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.
Claire van DijkDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.
Bhawani NagarajahCentre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands.
Sandra ImholzCentre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands.
Conny T van OostromCentre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands.
Erwin ReilingCentre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands.
Ákos GyenisFaculty of Medicine, CECAD, Institute for Genome Stability in Aging and Disease, University of Cologne, Cologne, Germany.
Pier G MastroberardinoDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.
Dick JaarsmaDepartment of Neuroscience, Erasmus University Medical Center, Rotterdam, Netherlands.
Harry van SteegCentre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands.
Jan H J HoeijmakersPrincess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Martijn E T DolléCentre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands.
Wilbert P VermeijPrincess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fragi.2022.1005322.].

Indexed as

aginganti-aging interventionsdietary restriction mimeticsDNA damage repairNADpharmacological screeningprogeria

Identifiers

PMID36506463
PMCPMC9727279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.